9MP-33590-60547
5 vaccinations
7 coded responses
46 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 212 / MD
- Registered
- 2021-02-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-16
Registered in v-safe
-
2021-02-16
Dose 1 — Pfizer-BioNTech
- 2021-02-16
- 2021-02-17
-
2021-02-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-02-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-02-20
-
2021-02-21
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-22
- 2021-02-23
- 2021-03-02
-
2021-03-09
Dose 2 — Pfizer-BioNTech
- 2021-03-09
-
2021-03-10
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Swollen, painful ancillary lymph nodes on same side as injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-11
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Swollen, painful auxiliary lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Still dealing with painful, swollen lymph nodes, but they are slowly improvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-13
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · HeadacheFree text: Lymph nodes are slowly resolving.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-04-20
- 2021-06-08
- 2021-09-07
-
2021-09-25
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Survey response — day 7, dose 3MedDRA: Headache, Reaction to previous exposure to any vaccine — Feeling: GoodFree text: I am a week out from my third booster. I did have a nasty headache starting post-injection day 2-4. The third booster was not as impactful as the second shot.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
-
2021-12-27
Survey response — 3 months, dose 3MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Major flair up of GERDMedDRA releases: 2024-11 · check-in free text available
-
2021-12-27
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-12-28
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-03-26
Survey response — 6 months, dose 3MedDRA: Labile blood pressure — Feeling: FairFree text: Labile blood pressure.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-01
Dose 4 — Pfizer-BioNTechCo-administered: Pneumonia
- 2022-05-12
- 2022-05-15
- 2022-05-22
- 2022-05-29
- 2022-06-05
- 2022-06-14
-
2022-10-10
Dose 5 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-30
- 2022-10-30
- 2022-10-31
- 2022-11-07
- 2022-11-14
- 2022-11-21
- 2023-01-09
- 2023-04-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-16 | Pfizer-BioNTech | |
| 2 | 2021-03-09 | Pfizer-BioNTech | |
| 3 | 2021-09-25 | Pfizer-BioNTech | No |
| 4 | 2022-05-01 | Pfizer-BioNTech | Pneumonia |
| 5 | 2022-10-10 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen, painful ancillary lymph nodes on same side as injection
Systemic reaction (other): Swollen, painful auxiliary lymph nodes
Systemic reaction (other): Still dealing with painful, swollen lymph nodes, but they are slowly improving
Systemic reaction (other): Lymph nodes are slowly resolving.
Release 9 — day 7, dose 3
Systemic reaction (other): I am a week out from my third booster. I did have a nasty headache starting post-injection day 2-4. The third booster was not as impactful as the second shot.
Release 10 — 3 months, dose 3
Symptoms: Major flair up of GERD
Release 11 — 6 months, dose 3
Symptoms: Labile blood pressure.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | · | · | ✓ |
| SD | Labile blood pressure | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Reaction to previous exposure to any vaccine | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release